Related Experiment Video
Updated: Aug 26, 2025

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
Published on: January 9, 2018
STING-induced regulatory B cells compromise NK function in cancer immunity
Sirui Li1,2,3, Bhalchandra Mirlekar1,2, Brandon M Johnson1,3
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Stimulator of interferon genes (STING) agonists can expand regulatory B cells, hindering anti-tumour immunity. Targeting this STING-IL-35 pathway in B cells may improve cancer therapy by enhancing natural killer cell responses.
Area of Science:
- Immunology
- Oncology
- Cancer Biology
Background:
- The tumor microenvironment often suppresses immune responses, limiting cancer treatment efficacy.
- Stimulator of Interferon Genes (STING) agonists activate innate immunity but face resistance in cancer therapies.
- Mechanisms underlying resistance to STING agonists in solid tumors remain unclear.
Purpose of the Study:
- To investigate the impact of STING agonists on the tumor microenvironment in pancreatic cancer.
- To elucidate the mechanisms by which STING agonists affect immune cells within tumors.
- To identify novel therapeutic strategies to overcome resistance to STING-based cancer therapies.
Main Methods:
- Administration of various STING agonists (including cGAMP) to human and mouse pancreatic cancer models.
- Analysis of B cell populations, specifically interleukin-35 (IL-35) expressing regulatory B cells.
- Assessment of STING signaling pathways (IRF3, type I interferon) in B cells.
- Evaluation of tumor control following STING pathway modulation in B cells.
- Investigation of the effects of IL-35 blockade or genetic ablation on tumor growth.
- Assessment of natural killer (NK) cell proliferation and anti-tumor activity.
Main Results:
- STING agonists, including cGAMP, induce expansion of IL-35+ regulatory B cells in pancreatic cancer.
- cGAMP-induced IL-35 expression in B cells is dependent on IRF3 but independent of type I interferon.
- Loss of STING signaling in B cells enhances tumor control in preclinical models.
- Blocking or ablating IL-35 in B cells reduces tumor growth.
- The STING-IL-35 axis in B cells suppresses natural killer (NK) cell proliferation and anti-tumor responses.
Conclusions:
- STING agonists can paradoxically promote immunosuppression by expanding regulatory B cells via the IL-35 pathway.
- This STING-IL-35 axis in B cells represents an intrinsic barrier to STING agonist monotherapy.
- Targeting the STING-IL-35 pathway in B cells, potentially combined with IL-35 blockade, offers a strategy to enhance NK cell-mediated anti-tumor immunity and overcome treatment resistance.
More Related Videos
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

